Page 9 - ஜா ஆய்வகம் வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

5 Best Pharmaceutical Stocks to Buy According to Billionaire Kerr Neilson Neilson’s Stake Value: $7,262,000 Percent of Kerr Neilson’s 13F Portfolio: 0.16% Number of Hedge Fund Holders: 30 Zai Lab Limited (NASDAQ: ZLAB) is a Chinese biopharmaceutical company that specialises in discovering, developing, licencing, and commercializing therapeutics for treatment of oncology, autoimmune, and infectious diseases. Early this year, the company announced its financial results for the second half and full year of 2020 in which it reported $49.0 million in total revenues for the FY 2020 compared to $13.0 million reported in the FY 2019. During the year, biopharmaceutical company’s sales of Optune amounted to $16.4 million compared to $6.4 million reported in the previous year. Zai Lab reported a net loss of $268.9 million or $3.46 per share in FY2020 compared to a net loss of $195.1 million or $3.03 per share reported in FY2019.

Hong kongKerr neilsonPoint therapeutics incZai labNumber of hedge fund holdersZai lab limitedPharmaceutical stocksBuy accordingBillionaire kerrLab limitedStake valueHedge fund holdersTurning point therapeuticsTurning pointஹாங் காங்கெர் நீல்சன்